Jacobs Levy Equity Management, Inc Meridian Bioscience Inc Transaction History

Jacobs Levy Equity Management, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$17.35 - $22.5 $173,829 - $225,427	-10,019 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$18.01 - $28.32 $180,442 - $283,738	10,019 New	10,019 $222,000
Q2 2020 Aug 17, 2020	SELL	$7.84 - $23.29 $285,854 - $849,176	-36,461 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$5.57 - $11.5 $1.11 Million - $2.29 Million	-199,065 Reduced 84.52%	36,461 $306,000
Q4 2019 Feb 14, 2020	BUY	$7.9 - $10.14 $1.86 Million - $2.39 Million	235,526 New	235,526 $2.3 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.